JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
RGEN Stock Price & Analysis - Repligen | Ledgeburg
RGEN - Repligen Corp.
USD | NASDAQ | Healthcare
Summary
Summary RGEN Stock
Financials
Financials RGEN Stock
Loading...
Loading...
Home
Stocks
Repligen Corp. (RGEN)
Stock Overview
Annual
Quarterly
Revenue $USD
0
200M
400M
600M
800M
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50M
100M
150M
200M
Q2 FY23
Q3 FY23
Q4 FY23
Q1 FY24
Q2 FY24
Q3 FY24
Q4 FY24
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Company Profile
No description available
Industry
Biotechnology
Sub-Industry
N/A
Employees
N/A
Founded
N/A
Company Website
N/A
Investor Relations
N/A
CEO
N/A
Headquarters
WALTHAM, MA